From: Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations
Ratio
90%Confidence Interval
Ln(C max )
1.13
0.95 – 1.35
Ln(AUC t )
1.10
0.92 – 1.32
Ln(AUC i )
1.12
0.95 – 1.32
Ln(C max /AUC i )
1.01
0.89 – 1.14
Ln(t 1/2 )
1.18
1.02 – 1.37
Ln(MRT)
1.07
0.97 – 1.20
t max
1.05
0.86 – 1.29